FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2003185617> ?p ?o ?g. }

• W2003185617 endingPage "212" @default.
• W2003185617 startingPage "201" @default.
• W2003185617 abstract "Non steroidal anti-inflammatory drugs (NSAIDs) are one of the categories of drugs most frequently used by elderly people, and maybe the most self-prescribed drugs. Both coronary events, and stroke, can be prevented by daily aspirin assumption. Other NSAIDs, except selective COX-2 inhibitors (coxibs), seem to reduce the incidence of cardiovascular events, but a definitive judgement is yet impossible. Moreover, these drugs cause more than 100,000 serious gastric adverse events each year in the US, and the risk increases exponentially in the elderly. Coxibs cause less gastric damage, but their cost is very high. Moreover, NSAIDs inhibit renal function and reduce the efficacy of diuretics and angiotensin converting enzyme (ACE) inhibitors, often used by elderly patients. Recent studies show that even COX-2 is important in the renal physiology, so that even coxibs appear not to be avoided of renal toxicity. Both gastric and renal toxicity induced by traditional NSAIDs and coxibs seem to be related to the fact that these drugs inhibit the synthesis of prostaglandins (PGs), but not those of leukotrienes (LTs), important mediators of inflammation and of many other physiopatological events. Newly developed anti-inflammatory drugs block both COX and the 5-LOX metabolic pathways, inhibiting the formation of PGs, thromboxanes (TXs) and LTs. The inhibition of the LT synthesis increases the anti-inflammatory efficacy (especially in pneumological and rheumatological diseases), reducing the risk of gastric damage. Even if preliminary data seem to be very interesting, further clinical safety data on these drugs obtained from elderly oriented trials need to be available before to give a final evaluation." @default.
• W2003185617 created "2016-06-24" @default.
• W2003185617 creator A5016384695 @default.
• W2003185617 creator A5026307792 @default.
• W2003185617 creator A5068440626 @default.
• W2003185617 date "2004-05-01" @default.
• W2003185617 modified "2023-10-09" @default.
• W2003185617 title "Clinical perspectives of anti-inflammatory therapy in the elderly: the lipoxigenase (LOX)/cycloxigenase (COX) inhibition concept" @default.
• W2003185617 cites W1546659053 @default.
• W2003185617 cites W1864987491 @default.
• W2003185617 cites W1955548028 @default.
• W2003185617 cites W1972160955 @default.
• W2003185617 cites W1972821304 @default.
• W2003185617 cites W1973498895 @default.
• W2003185617 cites W1996147253 @default.
• W2003185617 cites W2000346583 @default.
• W2003185617 cites W2024003742 @default.
• W2003185617 cites W2024233889 @default.
• W2003185617 cites W2026375486 @default.
• W2003185617 cites W2034981842 @default.
• W2003185617 cites W2040380614 @default.
• W2003185617 cites W2049067637 @default.
• W2003185617 cites W2062335942 @default.
• W2003185617 cites W2064144934 @default.
• W2003185617 cites W2066187800 @default.
• W2003185617 cites W2077143685 @default.
• W2003185617 cites W2082499830 @default.
• W2003185617 cites W2093559613 @default.
• W2003185617 cites W2096198355 @default.
• W2003185617 cites W2107864895 @default.
• W2003185617 cites W2118794261 @default.
• W2003185617 cites W2122283496 @default.
• W2003185617 cites W2123833658 @default.
• W2003185617 cites W2139480984 @default.
• W2003185617 cites W2152016833 @default.
• W2003185617 cites W2162810069 @default.
• W2003185617 cites W2167321599 @default.
• W2003185617 cites W2330056473 @default.
• W2003185617 cites W2330238464 @default.
• W2003185617 doi "https://doi.org/10.1016/j.archger.2003.10.001" @default.
• W2003185617 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15066307" @default.
• W2003185617 hasPublicationYear "2004" @default.
• W2003185617 type Work @default.
• W2003185617 sameAs 2003185617 @default.
• W2003185617 citedByCount "39" @default.
• W2003185617 countsByYear W20031856172012 @default.
• W2003185617 countsByYear W20031856172013 @default.
• W2003185617 countsByYear W20031856172014 @default.
• W2003185617 countsByYear W20031856172015 @default.
• W2003185617 countsByYear W20031856172016 @default.
• W2003185617 countsByYear W20031856172019 @default.
• W2003185617 countsByYear W20031856172020 @default.
• W2003185617 countsByYear W20031856172021 @default.
• W2003185617 countsByYear W20031856172022 @default.
• W2003185617 countsByYear W20031856172023 @default.
• W2003185617 crossrefType "journal-article" @default.
• W2003185617 hasAuthorship W2003185617A5016384695 @default.
• W2003185617 hasAuthorship W2003185617A5026307792 @default.
• W2003185617 hasAuthorship W2003185617A5068440626 @default.
• W2003185617 hasConcept C126322002 @default.
• W2003185617 hasConcept C127413603 @default.
• W2003185617 hasConcept C177713679 @default.
• W2003185617 hasConcept C181199279 @default.
• W2003185617 hasConcept C185592680 @default.
• W2003185617 hasConcept C197934379 @default.
• W2003185617 hasConcept C2776914184 @default.
• W2003185617 hasConcept C2777031258 @default.
• W2003185617 hasConcept C2777628954 @default.
• W2003185617 hasConcept C2779689624 @default.
• W2003185617 hasConcept C2780645631 @default.
• W2003185617 hasConcept C29730261 @default.
• W2003185617 hasConcept C535046627 @default.
• W2003185617 hasConcept C55493867 @default.
• W2003185617 hasConcept C71924100 @default.
• W2003185617 hasConcept C78519656 @default.
• W2003185617 hasConcept C98274493 @default.
• W2003185617 hasConceptScore W2003185617C126322002 @default.
• W2003185617 hasConceptScore W2003185617C127413603 @default.
• W2003185617 hasConceptScore W2003185617C177713679 @default.
• W2003185617 hasConceptScore W2003185617C181199279 @default.
• W2003185617 hasConceptScore W2003185617C185592680 @default.
• W2003185617 hasConceptScore W2003185617C197934379 @default.
• W2003185617 hasConceptScore W2003185617C2776914184 @default.
• W2003185617 hasConceptScore W2003185617C2777031258 @default.
• W2003185617 hasConceptScore W2003185617C2777628954 @default.
• W2003185617 hasConceptScore W2003185617C2779689624 @default.
• W2003185617 hasConceptScore W2003185617C2780645631 @default.
• W2003185617 hasConceptScore W2003185617C29730261 @default.
• W2003185617 hasConceptScore W2003185617C535046627 @default.
• W2003185617 hasConceptScore W2003185617C55493867 @default.
• W2003185617 hasConceptScore W2003185617C71924100 @default.
• W2003185617 hasConceptScore W2003185617C78519656 @default.
• W2003185617 hasConceptScore W2003185617C98274493 @default.
• W2003185617 hasIssue "3" @default.
• W2003185617 hasLocation W20031856171 @default.
• W2003185617 hasLocation W20031856172 @default.
• W2003185617 hasOpenAccess W2003185617 @default.
• W2003185617 hasPrimaryLocation W20031856171 @default.

• next